AIHealthcare Analytics

Knowledge Wiki

Wiki › Generative AI in Oncology and Immunotherapy — Applications and Evidence

Generative AI in Oncology and Immunotherapy — Applications and Evidence

OVERVIEW
Rev 1 Jul 6, 2026 18:44 UTC 9 sources

AI in Immunotherapy Optimization AI technologies have impacted cancer immunotherapy across response prediction, patient stratification for immune checkpoint blockade, and identification of potent T-cells for cellular therapies. Generative AI and foundation models have expanded applications to treatment plan generation and adverse event prediction. Emerging agentic AI and model context protocol (MCP) technologies are expected to further improve immunotherapy development and delivery. Key challenges include data quality control, patient safety, and ethical dilemmas. Breast Cancer AI Applications A scoping review of 54 studies (2016–2024) found machine learning as the predominant technology (81%) in post-diagnosis breast cancer care, followed by generative AI (7%), conversational agents (6%), NLP (4%), and data mining (2%). Follow-up and surveillance was the most represented care stage (48%), driven primarily by recurrence prediction. Most applications were provider-focused (83%); no studies addressed palliative care. Evidence was predominantly retrospective (70%) and concentrated in high-income countries (74%). Treatment Recommendation Quality A retrospective study of 100 advanced/recurrent breast cancer patients found ChatGPT scored higher than six board-certified breast cancer specialists across all five evaluation criteria including comprehensiveness of literature selection, accuracy of evidence interpretation, clinical appropriateness of treatment options, accuracy of…

Sources: harvested
🔒

Subscribe to read full wiki analysis

Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.

View Plans & Subscribe

New users get a 7-day trial — no credit card required.

← Back to Wiki Index